Retrospective study on the management and follow-up of 18 patients with a mid-urethral sling penetrating the urethra or bladder. En savoir plus sur Retrospective study on the management and follow-up of 18 patients with a mid-urethral sling penetrating the urethra or bladder.
SK3 Gene Polymorphism Is Associated with Taxane Neurotoxicity and Cell Calcium Homeostasis. En savoir plus sur SK3 Gene Polymorphism Is Associated with Taxane Neurotoxicity and Cell Calcium Homeostasis.
Successfully treatment by eribulin in visceral crisis: a case of lymphangitic carcinomatosis from metastatic breast cancer. En savoir plus sur Successfully treatment by eribulin in visceral crisis: a case of lymphangitic carcinomatosis from metastatic breast cancer.
Implementing Cognitive Training Into a Surgical Skill Course: A Pilot Study on Laparoscopic Suturing and Knot Tying. En savoir plus sur Implementing Cognitive Training Into a Surgical Skill Course: A Pilot Study on Laparoscopic Suturing and Knot Tying.
Prevalence of burnout, depression and job satisfaction among French senior and resident radiation oncologists. En savoir plus sur Prevalence of burnout, depression and job satisfaction among French senior and resident radiation oncologists.
Anterior and middle pelvic organ prolapse repair using a six tension-free strap low weight transvaginal mesh: long-term retrospective monocentric study of 311 patients. En savoir plus sur Anterior and middle pelvic organ prolapse repair using a six tension-free strap low weight transvaginal mesh: long-term retrospective monocentric study of 311 patients.
Darolutamide in Nonmetastatic Castration-Resistant Prostate Cancer. En savoir plus sur Darolutamide in Nonmetastatic Castration-Resistant Prostate Cancer.
Filgrastim prophylaxis in elderly cancer patients in the real-life setting: a French multicenter observational study the TULIP study. En savoir plus sur Filgrastim prophylaxis in elderly cancer patients in the real-life setting: a French multicenter observational study the TULIP study.
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre open-label phase 3 randomised trial. En savoir plus sur 6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre open-label phase 3 randomised trial.
Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort. En savoir plus sur Overall and progression-free survival with cabazitaxel in metastatic castration-resistant prostate cancer in routine clinical practice: the FUJI cohort.